Literature DB >> 7874203

Regulation of the MAP kinase cascade.

M H Cobb1, S Xu, J E Hepler, M Hutchison, J Frost, D J Robbins.   

Abstract

The MAP kinase cascade is regulated by many hormones and growth factors and its activation leads to changes in properties of cytoplasmic, membrane-associated, and nuclear proteins. The MAP kinases themselves are activated by MEKS. MEKs lie at a point of convergence for multiple upstream signals, mediated by distinct protein kinases, Raf, MEK kinase, and Mos, all of which have MEK kinase activity. Additional inputs that stimulate the MAP kinase pathway are the activation of protein kinase C and the yeast protein kinase STE20. Mechanisms of regulation of some of the upstream components of this cascade have not yet been fully elucidated.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7874203

Source DB:  PubMed          Journal:  Cell Mol Biol Res        ISSN: 0968-8773


  17 in total

1.  A role for K-ras in conferring resistance to the MEK inhibitor, CI-1040.

Authors:  Yuli Wang; Keri Van Becelaere; Ping Jiang; Sally Przybranowski; Charles Omer; Judith Sebolt-Leopold
Journal:  Neoplasia       Date:  2005-04       Impact factor: 5.715

Review 2.  Substrate and docking interactions in serine/threonine protein kinases.

Authors:  Elizabeth J Goldsmith; Radha Akella; Xiaoshan Min; Tianjun Zhou; John M Humphreys
Journal:  Chem Rev       Date:  2007-10-19       Impact factor: 60.622

Review 3.  Molecular basis of MAP kinase regulation.

Authors:  Wolfgang Peti; Rebecca Page
Journal:  Protein Sci       Date:  2013-10-19       Impact factor: 6.725

4.  Transactivation of Fra-1 and consequent activation of AP-1 occur extracellular signal-regulated kinase dependently.

Authors:  Matthew R Young; Rajalakshmi Nair; Natalie Bucheimer; Preety Tulsian; Nicole Brown; Cristi Chapp; Tin-Chen Hsu; Nancy H Colburn
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

5.  Emergence of activity-dependent, bidirectional control of microtubule-associated protein MAP2 phosphorylation during postnatal development.

Authors:  E M Quinlan; S Halpain
Journal:  J Neurosci       Date:  1996-12-01       Impact factor: 6.167

6.  Growth factor activation of MAP kinase requires cell adhesion.

Authors:  M W Renshaw; X D Ren; M A Schwartz
Journal:  EMBO J       Date:  1997-09-15       Impact factor: 11.598

7.  Structural basis of p38α regulation by hematopoietic tyrosine phosphatase.

Authors:  Dana M Francis; Bartosz Różycki; Dorothy Koveal; Gerhard Hummer; Rebecca Page; Wolfgang Peti
Journal:  Nat Chem Biol       Date:  2011-11-06       Impact factor: 15.040

Review 8.  Role of taurine, its haloamines and its lncRNA TUG1 in both inflammation and cancer progression. On the road to therapeutics? (Review).

Authors:  Stella Baliou; Anthony M Kyriakopoulos; Demetrios A Spandidos; Vassilios Zoumpourlis
Journal:  Int J Oncol       Date:  2020-07-14       Impact factor: 5.650

9.  Tamoxifen resistance in breast cancer cells is accompanied by an enhanced motile and invasive phenotype: inhibition by gefitinib ('Iressa', ZD1839).

Authors:  Stephen Hiscox; Liam Morgan; Denise Barrow; Carol Dutkowskil; Alan Wakeling; Robert I Nicholson
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

10.  Thrombin induces fibroblast CCL2/JE production and release via coupling of PAR1 to Galphaq and cooperation between ERK1/2 and Rho kinase signaling pathways.

Authors:  Xiaoling Deng; Paul F Mercer; Chris J Scotton; Annette Gilchrist; Rachel C Chambers
Journal:  Mol Biol Cell       Date:  2008-03-19       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.